Form 4: Prestige Consumer Healthcare Exec Trades Shares
Insider Transaction Report
Jeffrey Zerillo, Senior VP Operations at Prestige Consumer Healthcare Inc., reported transactions involving company common stock on May 5, 2026.
Summary
- Jeffrey Zerillo, Senior VP Operations at Prestige Consumer Healthcare Inc. (PBH), reported stock transactions on May 5, 2026.
- Zerillo acquired 307 shares of common stock at a price of $55.75 per share.
- Concurrently, Zerillo disposed of 1,207 shares of common stock at a price of $54.99 per share.
- Following these transactions, Zerillo beneficially owns 42,820 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions without indicating a significant change in beneficial ownership or providing new strategic information.
Future Outlook
This filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the trading activities of company executives and directors. These filings are closely watched by investors for potential signals about management's confidence in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 08/07/2018 | Date of power of attorney filed with the Commission. |
| 05/05/2026 | Earliest transaction date and transaction date for stock acquisition and disposition. |
| 05/07/2026 | Date of report filing. |
Keywords
Prestige Consumer Healthcare, PBH, Form 4, Insider Trading, Stock Transaction, Beneficial Ownership, Common Stock, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.